Evidence map›Paper›PMID 29495537›Full record

ArticleViruses2018

DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.

Lara Ajamian, Luca Melnychuk, Patrick Jean-Pierre, Gerasimos J Zaharatos

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.International journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lara AjamianLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada. lara.ajamian@mail.mcgill.ca.
Luca MelnychukLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada. luca.melnychuk@mail.mcgill.ca.
Patrick Jean-PierreLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada. patjp2106@gmail.com.
Gerasimos J ZaharatosLady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC H3T 1E2, Canada. gerasimos.zaharatos@mcgill.ca.ORCID 0000-0003-0656-0714
Jewish General Hospital · CA

Funding

CIHR GSM-129996CIHR THA-118628
6 · The paper itself

Abstract

Flagellin's potential as a vaccine adjuvant has been increasingly explored over the last three decades. Monomeric flagellin proteins are the only known agonists of Toll-like receptor 5 (TLR5). This interaction evokes a pro-inflammatory state that impacts upon both innate and adaptive immunity. While pathogen associated molecular patterns (PAMPs) like flagellin have been used as stand-alone adjuvants that are co-delivered with antigen, some investigators have demonstrated a distinct advantage to incorporating antigen epitopes within the structure of flagellin itself. This approach has been particularly effective in enhancing humoral immune responses. We sought to use flagellin as both scaffold and adjuvant for HIV gp41 with the aim of eliciting antibodies to the membrane proximal external region (MPER). Accordingly, we devised a straightforward step-wise approach to select flagellin-antigen fusion proteins for gene-based vaccine development. Using plasmid DNA vector-based expression in mammalian cells, we demonstrate robust expression of codon-optimized full length and hypervariable region-deleted constructs of

Indexed as

Adjuvants, ImmunologicAIDS VaccinesAnimalsCell LineDisease Models, AnimalFemaleFlagellinGene ExpressionGenetic VectorsHIV-1HIV Envelope Protein gp41HIV InfectionsHumansImmunity, HumoralImmunogenicity, VaccineImmunoglobulin GAdjuvants, ImmunologicAIDS VaccinesFlagellinHIV Envelope Protein gp41Immunoglobulin GToll-Like Receptor 5Vaccines, DNAadjuvantDNA vaccineflagellingp41HIV-1membrane proximal external regionMPER

Identifiers

PMID29495537
PMCPMC5869493
OpenAlexW2789336047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.